Skip to content
GenoLensGenoLens

NSF

Chr 17q21.31

N-ethylmaleimide sensitive factor, vesicle fusing ATPase

Aliases:
SKD2, SEC18
MANE:
ENST00000398238.8

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Early onset or syndromic epilepsy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • developmental and epileptic encephalopathy 96

    0.56
  • neurodegenerative disease

    0.53
  • Abnormality of the skeletal system

    0.36
  • atrial fibrillation

    0.34
  • androgenetic alopecia

    0.31
  • Anxiety

    0.26
  • idiopathic pulmonary fibrosis

    0.26
  • dermatomycosis

    0.25
  • dermatophytosis

    0.25
  • functional laterality

    0.25

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Vesicle-fusing ATPase

Required for vesicle-mediated transport. Catalyzes the fusion of transport vesicles within the Golgi cisternae. Is also required for transport from the endoplasmic reticulum to the Golgi stack. Seems to function as a fusion protein required for the delivery of cargo proteins to all compartments of the Golgi stack independent of vesicle origin. Interaction with AMPAR subunit GRIA2 leads to influence GRIA2 membrane cycling (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.